Envue Medical Inc (FEED) Stock Price, Quote & News

Company Profile

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The c...

Industry: Medical Devices

Sector: Healthcare

Phone: (914) 233-3004

Website: envuemed.com

Address:

969 Pruitt Ave, Tyler, United States

Tryitin Jan. 15 at 2:49 AM

$FEED $SGBX Agreed. We have long time before Jan 28 meetign for SGBX to have an episode of SQUEEZE soon which is already long due now...PAYtience pays here IMO !

0 · Reply

Larry0829 Jan. 15 at 2:46 AM

$FEED trust me bro……

0 · Reply

Larry0829 Jan. 15 at 2:45 AM

$FEED if I say Santa is real with no documentation to back it up, does that make him real? 🤔

0 · Reply

Inlowouthigh Jan. 15 at 2:37 AM

$FEED float is 9 million

0 · Reply

superhops Jan. 15 at 2:36 AM

$FEED With only 1 million share float, how does it trade 22 million shares in one session? I understand that the same shares can be bought and sold many times in the same day but this does seem rather excessive. Especially since it seems many of us just held a position.

1 · Reply

victory369 Jan. 15 at 1:22 AM

$FEED Who is think it’s going up tomorrow? 😁

0 · Reply

Larry0829 Jan. 15 at 1:08 AM

$FEED I’m buying more after I handle my margin call 😀

0 · Reply

Larry0829 Jan. 15 at 12:52 AM

$FEED

0 · Reply

JustAnotherGuy007 Jan. 15 at 12:50 AM

$FEED Sorry wrong math. About 10% got shorted today.

0 · Reply

JustAnotherGuy007 Jan. 15 at 12:43 AM

$FEED Short Interest is released by Finra every 15 days. The last one got released on 12/31 and here is that data . Will publish tomorrow if I see the revised short interest.

0 · Reply

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

Dec 18, 2025, 12:30 PM EST - 27 days ago

ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

Dec 15, 2025, 9:00 AM EST - 4 weeks ago

ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

Dec 12, 2025, 8:00 AM EST - 4 weeks ago

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED'

Nov 19, 2025, 8:00 AM EST - 2 months ago

NanoVibronix Issues Letter to Shareholders

Sep 18, 2025, 8:00 AM EDT - 4 months ago

NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

Sep 16, 2025, 3:57 PM EDT - 4 months ago

NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 15, 2025, 8:00 AM EDT - 4 months ago

NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio

Sep 4, 2025, 8:00 AM EDT - 4 months ago

NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology

Aug 8, 2025, 9:00 AM EDT - 5 months ago

NanoVibronix Announces Reverse Stock Split

Jul 18, 2025, 9:00 AM EDT - 6 months ago

NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock

Jun 26, 2025, 8:00 AM EDT - 7 months ago

NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation

Jun 24, 2025, 8:00 AM EDT - 7 months ago

NanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement

Jun 11, 2025, 8:00 AM EDT - 7 months ago

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

Jun 4, 2025, 8:38 AM EDT - 8 months ago

NanoVibronix Announces CEO Transition

May 28, 2025, 4:22 PM EDT - 8 months ago

NanoVibronix Responds to False Post

May 28, 2025, 8:00 AM EDT - 8 months ago

Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures

May 16, 2025, 4:30 PM EDT - 8 months ago

NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants

May 15, 2025, 9:00 AM EDT - 8 months ago

NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants

May 12, 2025, 8:50 AM EDT - 8 months ago

NanoVibronix Announces Results from UroShield™ Case Series

Apr 11, 2025, 8:00 AM EDT - 9 months ago

NanoVibronix Regains Nasdaq Compliance

Apr 1, 2025, 8:00 AM EDT - 10 months ago

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

Mar 14, 2025, 8:00 AM EDT - 10 months ago

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

Feb 14, 2025, 9:43 AM EST - 11 months ago

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

Jan 7, 2025, 8:00 AM EST - 1 year ago

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

Jan 6, 2025, 8:00 AM EST - 1 year ago

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

Dec 11, 2024, 8:00 AM EST - 1 year ago

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

Nov 12, 2024, 8:00 AM EST - 1 year ago

NanoVibronix Provides Business Update

Oct 9, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

Sep 23, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Signs Letter of Intent with Potential New Distributor

Aug 21, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

May 22, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

May 16, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Issues Letter to Stockholders

May 14, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

May 1, 2024, 8:00 AM EDT - 1 year ago

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award

Apr 24, 2024, 1:00 PM EDT - 1 year ago

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

Mar 28, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

Dec 6, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Featured in Your Bladder Health Magazine

Dec 4, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

Nov 28, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan

Nov 7, 2023, 8:30 AM EST - 2 years ago

NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1

Sep 27, 2023, 8:00 AM EDT - 2 years ago

NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

Sep 6, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

Aug 30, 2023, 2:29 PM EDT - 2 years ago

NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Aug 30, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Cites Positive Results from Independent Testing of UroShield

Aug 29, 2023, 4:05 PM EDT - 2 years ago

NanoVibronix Responds to CMS' Determination for PainShield

Aug 28, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

Aug 23, 2023, 8:45 AM EDT - 2 years ago

NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus

Jun 14, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard

Mar 28, 2023, 8:30 AM EDT - 3 years ago

NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)

Tryitin Jan. 15 at 2:49 AM

$FEED $SGBX Agreed. We have long time before Jan 28 meetign for SGBX to have an episode of SQUEEZE soon which is already long due now...PAYtience pays here IMO !

0 · Reply

Larry0829 Jan. 15 at 2:46 AM

$FEED trust me bro……

0 · Reply

Larry0829 Jan. 15 at 2:45 AM

$FEED if I say Santa is real with no documentation to back it up, does that make him real? 🤔

0 · Reply

Inlowouthigh Jan. 15 at 2:37 AM

$FEED float is 9 million

0 · Reply

superhops Jan. 15 at 2:36 AM

1 · Reply

victory369 Jan. 15 at 1:22 AM

$FEED Who is think it’s going up tomorrow? 😁

0 · Reply

Larry0829 Jan. 15 at 1:08 AM

$FEED I’m buying more after I handle my margin call 😀

0 · Reply

Larry0829 Jan. 15 at 12:52 AM

$FEED

0 · Reply

JustAnotherGuy007 Jan. 15 at 12:50 AM

$FEED Sorry wrong math. About 10% got shorted today.

0 · Reply

JustAnotherGuy007 Jan. 15 at 12:43 AM

$FEED Short Interest is released by Finra every 15 days. The last one got released on 12/31 and here is that data . Will publish tomorrow if I see the revised short interest.

0 · Reply

JustAnotherGuy007 Jan. 15 at 12:38 AM

$FEED Some hope for a run again in future It’s brutal , the entire float has been shorted today !! I guess it got shorted when volume started going up. Shorts have to recover within T+2 days, and everyday after that CTB will keep increasing.

0 · Reply

Theman22 Jan. 15 at 12:31 AM

$FEED holding will buy more if it gets pushed lower

0 · Reply

_loutrades_ Jan. 15 at 12:31 AM

$FEED brutal af today

0 · Reply

Larry0829 Jan. 15 at 12:26 AM

$FEED

0 · Reply

koksmak Jan. 14 at 11:58 PM

$FEED I'm in dis bit til 10 plus.

0 · Reply

brimley Jan. 14 at 11:44 PM

$FEED Do not panic sell. This is the same setup now as $SGBX six weeks ago. Price tripled in 4 days thanks to naked short sellers and micro float. NASDAQ attention was drawn here today and the short sellers jumped on it. Patience will pay off here big time.

3 · Reply

Thralling Jan. 14 at 11:44 PM

$FEED ENvue Medical, Inc. (NASDAQ: FEED) has approximately 1.09 million (1.09M) shares outstanding, a figure consistent across financial data sites, representing the total shares held by investors, including insiders. I am going to bed good night bulls.

0 · Reply

Thralling Jan. 14 at 11:29 PM

$FEED They issued shares and warrants in September 2025 at a price around $7 per unit and earlier in May 2025, raising funds to manage existing debt.

0 · Reply

Thralling Jan. 14 at 11:25 PM

$FEED all the shorts in here scaring you. This is all shorts. Illegal shorting. The company doesn't run the market makers. Up with the stock and the company down with illegal naked shorting. No offering not reverse split they want you to panic and you did.

2 · Reply

yft212 Jan. 14 at 11:22 PM

$FEED Thank God I only bought 100 shares.

0 · Reply

Larry0829 Jan. 14 at 11:22 PM

$FEED

0 · Reply

Larry0829 Jan. 14 at 11:18 PM

$FEED I didn’t realize Nasdaq lets companies who commit securities fraud ring the opening bell……

1 · Reply

Market Cap	2.53M
Revenue (ttm)	2.56M
Net Income (ttm)	-3.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-144.92%
Debt to Equity Ratio	0.02

Volume	22,637,000
Avg Vol	613,858
Day's Range	N/A - N/A
Shares Out	1.09M
Stochastic %K	8%
Beta	2.09
Analysts	Strong Buy
Price Target	$3.50